Italia markets close in 6 hours 16 minutes

FTSE MIB
34.483,22
-176,33(-0,51%)
Dow Jones
38.852,86
-216,74(-0,55%)
Nasdaq
17.019,88
+99,08(+0,59%)
Nikkei 225
38.556,87
-298,50(-0,77%)
Petrolio
80,45
+0,62(+0,78%)
Bitcoin EUR
62.571,14
-223,73(-0,36%)

NVCR Jan 2025 17.500 call

OPR - OPR Prezzo differito. Valuta in USD.

Aggiungi a watchlist

8,00

0,00

(0,00%)

In data: 10:31AM EDT. Mercato aperto.

GlobeNewswire
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor Treating Fields therapy together with immune checkpoint inhibitors resulted in an unprecedented 8-month improvement in median overall survival LUNAR is the first phase 3 clinical trial in more than seven years to show a significant extension in overall survival in